Back
Partners Group Holding AG Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
32
PGPHF
Partners Group Holding AG
Last Price:
$1,292.59
Seasonality Move:
2.97%
Buy
54
SRPT
Sarepta Therapeutics
Last Price:
$53.80
Seasonality Move:
12.51%
Sell
32
Partners Group Holding AG (PGPHF)
is a Sell
Is Partners Group Holding AG a Buy, Sell or Hold?
-
The current Partners Group Holding AG [PGPHF] share price is $1,287.23. The Score for PGPHF is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
PGPHF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $53.94. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PGPHF Stock Price Chart
What is Partners Group Holding AG's stock price today?
-
The Partners Group Holding AG share price today is $1,287.23Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PGPHF is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $53.94Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
PGPHF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -59.54 | Sell |
Relative Strength Index (14 RSI): | 42.85 | Sell |
Chaikin Money Flow: | -10 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1260.61 - 1507.09) | Sell |
Bollinger Bands (100): | (1348.72 - 1534.66) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -10.59 | Sell |
Relative Strength Index (14 RSI): | 31.57 | Sell |
Chaikin Money Flow: | -108555 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.57 - 82.31) | Sell |
Bollinger Bands (100): | (80.58 - 128.2) | Sell |
PGPHF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1237.25 | Buy |
20-day SMA: | 1358.9 | Sell |
50-day SMA: | 1452.65 | Sell |
200-day SMA: | 1419.49 | Sell |
8-day EMA: | 1281.38 | Buy |
20-day EMA: | 1334.87 | Sell |
50-day EMA: | 1405.04 | Sell |
200-day EMA: | 1411 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.71 | Buy |
20-day SMA: | 61.78 | Sell |
50-day SMA: | 87.56 | Sell |
200-day SMA: | 119.05 | Sell |
8-day EMA: | 54.67 | Sell |
20-day EMA: | 63.17 | Sell |
50-day EMA: | 81.41 | Sell |
200-day EMA: | 108.77 | Sell |
Partners Group Holding AG Earnings Growth & PGPHF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.11 per share, an increase this year of $3.98 per share, and an increase next year of $6.27 per share.
Partners Group Holding AG Technical Analysis
Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |